Baseline characteristics
| Increased BP (193) | Stable BP (150) | P value | |
| Age | 81 (74–85) | 81 (74–86) | 0.802 |
| Male sex | 96 (50) | 96 (64) | 0.009 |
| BMI | 29.55 (26.43–34.29) | 29.66 (26.05–32.99) | 0.668 |
| Caucasian race | 191 (99) | 149 (99) | 1.000 |
| EuroSCORE (%) | 7.09 (4.50–11.28) | 6.96 (4.77–10.08) | 0.523 |
| STS risk score (%) | 5.4 (3.6–8.8) | 6.1 (4.0–9.1) | 0.178 |
| Preprocedural HTN | 172 (89) | 130 (87) | 0.506 |
| Preprocedural CAD | 145 (75) | 107 (71) | 0.461 |
| Baseline ejection fraction <40% | 23 (12) | 26 (17) | 0.165 |
| Preprocedural NYHA class III or IV symptoms | 85 (44) | 67 (45) | 0.913 |
| Preprocedural DM | 70 (36) | 52 (35) | 0.820 |
| Prior stroke/TIA | 27 (14) | 12 (8) | 0.089 |
| Preprocedural atrial fibrillation | 54 (28) | 50 (33) | 0.290 |
| Preprocedural eGFR <60 mL/min | 95 (49) | 69 (46) | 0.587 |
| Preprocedural AAA | 18 (9) | 20 (13) | 0.298 |
| Preprocedural carotid artery stenosis >50% or prior CEA | 54 (28) | 39 (26) | 0.715 |
| Preprocedural dyslipidaemia | 171 (89) | 134 (89) | 0.864 |
| Prior CABG | 57 (30) | 40 (27) | 0.629 |
| Prior PCI | 65 (34) | 61 (41) | 0.214 |
| Prior permanent pacemaker | 24 (12) | 17 (11) | 0.867 |
| Prior aortic valvuloplasty | 31 (16) | 28 (19) | 0.565 |
Values are median (IQR) or n (%).
AAA, abdominal aortic aneurysm; BMI, body mass index; BP, blood pressure; CABG, coronary artery bypass graft;CAD, coronary artery disease; CEA, carotid endarterectomy; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate HTN, hypertension; NYHA, New York Heart Association; PCI, percutaneous coronary intervention; STS, TIA, transient ischaemic attack.